Cargando…

Circulating dipeptidyl peptidase (cDPP3)—A marker for end‐stage heart failure?

Detalles Bibliográficos
Autores principales:	Pavo, Noemi, Prausmüller, Suriya, Spinka, Georg, Goliasch, Georg, Bartko, Philipp E, Arfsten, Henrike, Santos, Karine, Strunk, Guido, Hülsmann, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303376/ https://www.ncbi.nlm.nih.gov/pubmed/34982489 http://dx.doi.org/10.1111/joim.13449

Ejemplares similares

Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
por: Prausmüller, Suriya, et al.
Publicado: (2020)

Neutrophil Activation/Maturation Markers in Chronic Heart Failure with Reduced Ejection Fraction
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Malnutrition outweighs the effect of the obesity paradox
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic
por: Han, Emilie, et al.
Publicado: (2023)

Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure
por: Arfsten, Henrike, et al.
Publicado: (2021)

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Increased concentrations of bioactive adrenomedullin subsequently to angiotensin‐receptor/neprilysin‐inhibitor treatment in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2020)

An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid Regurgitation
por: Spinka, Georg, et al.
Publicado: (2020)

Relevance of Neutrophil Neprilysin in Heart Failure
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study
por: Bartko, Philipp E, et al.
Publicado: (2021)

Secondary mitral regurgitation—Insights from microRNA assessment
por: Spinka, Georg, et al.
Publicado: (2020)

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer
por: Arfsten, Henrike, et al.
Publicado: (2021)

Neprilysin as a Biomarker: Challenges and Opportunities
por: Pavo, Noemi, et al.
Publicado: (2020)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2019)

The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
por: Pavo, Noemi, et al.
Publicado: (2019)

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020)

Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure
por: Pavo, Noemi, et al.
Publicado: (2019)

GDF‐15 in solid vs non‐solid treatment‐naïve malignancies
por: Arfsten, Henrike, et al.
Publicado: (2019)

Metabolomics implicate eicosanoids in severe functional mitral regurgitation
por: Hofbauer, Thomas M., et al.
Publicado: (2022)

Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction
por: Pavo, Noemi, et al.
Publicado: (2018)

Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013)

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
por: Solerte, Sebastiano Bruno, et al.
Publicado: (2020)

Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
por: Sebastián-Martín, Alba, et al.
Publicado: (2022)

A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation
por: Heitzinger, Gregor, et al.
Publicado: (2023)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010)

Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis
por: Schulz, Kirsten, et al.
Publicado: (2015)

Neuronal Roles of the Multifunctional Protein Dipeptidyl Peptidase-like 6 (DPP6)
por: Malloy, Cole, et al.
Publicado: (2022)

Identification of Dipeptidyl-Peptidase (DPP)5 and DPP7 in Porphyromonas endodontalis, Distinct from Those in Porphyromonas gingivalis
por: Nishimata, Haruka, et al.
Publicado: (2014)

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
por: Zhang, Tianli, et al.
Publicado: (2021)

Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes
por: Zilleßen, Pia, et al.
Publicado: (2016)

Rebound increase in circulating dipeptidyl peptidase 4 (DPP4) enzyme activity after acute COVID-19
por: Firneisz, Gábor
Publicado: (2023)

Dipeptidyl Amino-Peptidase 3 (DPP3) as an Early Marker of Severity in a Patient Population with Cardiogenic Shock
por: Innelli, Pasquale, et al.
Publicado: (2023)

The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups
por: Kountz, David
Publicado: (2013)

Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
por: Lee, Jung Min, et al.
Publicado: (2019)

Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
por: Barchetta, Ilaria, et al.
Publicado: (2022)

Heart Failure With Reduced Ejection Fraction Is Characterized by Systemic NEP Downregulation
por: Pavo, Imre J., et al.
Publicado: (2020)

Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data
por: Frey, Maria Klara, et al.
Publicado: (2021)

Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate
por: Liu, Rui, et al.
Publicado: (2017)

Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
por: Ługowska, Agnieszka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mis3q0c0okhoeor68fr7vct4t6